ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2026, Vol 16, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. M2 Macrophages-Based Immunotherapy: A New Therapeutic Approach in Liver Fibrosis

Wahyu Widowati* , Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Elham Rismani* , Massoud Vosough*

Adv Pharm Bull. 2025;15(2): 314-325. doi: 10.34172/apb.025.43855

PMCID: PMC12413974 PMID: 40922738

Article

PDF

Full Text

XML

Cited By:

Original Article

2. Dual Modulation of Senescence and Immune Checkpoints by Metformin and Dapagliflozin Attenuates Liver Fibrosis in a Thioacetamide-Induced Rat Model

Asmaa Ramadan, Ahmed A. Shaaban, Mohammad E. Rabeh, Ahmad M. Rabi, Eslam E. Abd El-Fattah, Amal K. Seleem, Ibrahim Osman, Ayman Salama, Noha M. Gamil, Ahmed S.G. Srag El-Din*

Adv Pharm Bull. 2026;16(1): 166-178. doi: 10.34172/apb.025.46231

Article

PDF

XML

Cited By:

Original Article

3. Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway

Samaneh Siapoush , Mohammad Rahmati* , Morteza Milani, Behzad Hatami, Nosratollah Zarghami, Abbas Ebrahimi-Kalan, Mohammad Reza Zali, Kaveh Baghaei*

Adv Pharm Bull. 2025;15(1): 107-122. doi: 10.34172/apb.43295

PMCID: PMC12235369 PMID: 40636301

Article

PDF

Full Text

XML

Cited By: